A randomized controlled pilot trial: Comparison of 14 and 24 French thoracic drainage after minimally invasive lobectomy – MZ 14-24 study - MZ 14-24 Study

niversitäres Thoraxzentrum Mainz0 个研究点目标入组 40 人开始时间: 2022年9月15日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Inclusion criteria are all patients over 18 years who are targeted for anatomic lobectomy using a minimally invasive technique, regardless of whether the lesion is benign, primary bronchial carcinoma, or pulmonary metastasis from another primary.
•Written informed consent from patients is assumed.
•Also included will be patients who undergo subsequent lobectomy after an intraoperative frozen section (wedge resection/segmental resection).

•The following subjects were excluded:
•- No lobectomy using minimally invasive technique (wedge resection extension, bilobectomy/pneumonectomy, conversion thoracotomy).
•- Creation of a 2nd trocar access
•- History of congenital/acquired coagulopathy
•- Use of direct oral anticoagulants
•- Intraoperative evidence of severe adhesions (adhesions involving a complete lobe of the lung that is not resected. Large, wide adhesions that must be released using sharp dissection).
•- Deviation from standard postoperative pain management regimen (patient refusal of paravertebral catheter/pain medication).
•- Chronic analgesic therapy

发起方

niversitäres Thoraxzentrum Mainz